Clinical Development · Medical Writing
Evidence, Translated
Into Approval.
Regulatory documents written to ICH standards — protocols, CSRs, IBs, patient narratives, and CTD Module 2 summaries ready for submission.
ICH E3Compliant
Overview
Documents Built for Regulatory Clarity
Clinical medical writing is not a documentation exercise — it is the process by which your evidence is translated into the regulatory arguments that health authorities use to make approval decisions. Our clinical writing services produce documents that are scientifically accurate, structurally compliant with ICH requirements, and written with enough clarity that a reviewer can follow your data from first table reference to final conclusion without ambiguity. Every document we produce is traceable to source and ready for submission. Sponsors who treat clinical medical writing as a late-stage activity consistently encounter the same problem: inconsistencies between statistical output and narrative that require costly re-review cycles. We engage early and stay engaged throughout.
- Protocols, CSRs, IBs and narratives
- ICH E3-compliant, source-traceable documents
- CTD Module 2.5 / 2.7 summaries
- Works within your governance framework
What We Deliver
Capabilities Across Every Stage
Three integrated disciplines, delivered by senior specialists as one accountable programme.
Study Documentation
Our clinical documentation writing covers the full spectrum of regulatory deliverables a pharma programme requires. Pharma documentation services are scoped to your timeline and resource needs — whether you need a single protocol written from scratch or a full suite of submission documents produced concurrently. Study reports writing begins with a structured outline agreed with your medical, statistical, and regulatory teams; every section is drafted against source data and reviewed for internal consistency before it leaves our team. CRO writing services integrate with your existing review processes — our writers work within your governance framework, not parallel to it.
Protocols, CSRs, IBs
Protocol writing services begin at the feasibility stage — reviewing scientific objectives, endpoint definitions, and statistical assumptions before a word of protocol text is drafted. Protocol amendments are managed with full version control and impact assessment documentation. CSR writing clinical experience covers ICH E3-compliant reports for Phase I through Phase IV studies, with patient narratives writing treated with the same rigour as the main CSR body because it receives the same regulatory scrutiny. Investigator brochure updates are managed on both scheduled and triggered timelines, incorporating emerging safety data and updated pharmacokinetic findings coherently and in compliance with ICH E6 and M3 requirements.
Compliance & Quality
Regulatory clinical writing requires understanding of what each agency expects to see, at what level of detail, in what document format. Our writers have direct experience with FDA, EMA, MHRA, and ICH submission requirements. Trial reporting services include final study reports, interim analysis reports, and DSMB summary documents — all written to the same standard of regulatory clarity. Every document undergoes a structured quality review against source data and applicable ICH guidance before delivery. For sponsors requiring global clinical writing services USA EU with a consistent quality standard across markets, our team manages parallel document development across jurisdictions — CRO medical writing worldwide.
ICH E3CSR Standard
4Global Regions
CTDModule 2 Ready
ISO 90012015 Quality System
Key Deliverables
What You Receive
Tangible, submission-ready outputs — not status updates.
Study Protocol & Amendments
Complete, ethics-ready protocol with managed version control for all amendments.
Investigator's Brochure (IB)
Annual and triggered updates reflecting current safety and clinical knowledge, compliant with ICH E6.
Clinical Study Report (CSR)
ICH E3-compliant report including full statistical output integration and patient narratives.
Patient Narratives
Individual narratives for serious adverse events and deaths, written to regulatory standard.
CTD Module 2.5 / 2.7 Summaries
Clinical overview and summary for NDA, MAA, and BLA submissions in CTD format.
Why Vigilare
Why Sponsors Choose Vigilare
What sets this engagement apart from a generic vendor.
Scientific Depth
Writers hold advanced scientific degrees in relevant therapeutic disciplines — they understand the science they are writing about, not just the document structure it needs to follow.
Source-Data Traceability
Source-data traceability as standard — every table, listing, and data point in a CSR or Module 2 summary is traceable back to the source dataset before the document leaves our team.
Structured QC Process
Structured QC process against ICH E3 and relevant agency guidance applied to every document regardless of size — not reserved for pivotal study CSRs.
Multi-Agency Experience
Regulatory submission experience across FDA, EMA, MHRA, PMDA, ANVISA, and TGA — with writers familiar with the specific format and content preferences of each agency.
Who We Work With
Configured to Your Model
We engage differently depending on the function you already have in place.
NDA / MAA Sponsors
Challenge
Require ICH E3-compliant CSRs and Module 2 summaries for regulatory submission under time pressure
How We Help
Submission-ready documents with structured review cycles and defined delivery timelines.
Emerging Biotech
Challenge
Lack internal writing resource and need documents written to regulatory standard from scratch
How We Help
We act as your embedded writing team across the full protocol-to-submission arc.
Late-Stage Clinical Programmes
Challenge
Need patient narratives, IB updates, and integrated summaries written concurrently with close-out
How We Help
Parallel document development resourced to match study timelines without quality compromise.
FAQs
Clinical Medical Writing, Answered.
01
What is clinical medical writing?
Clinical medical writing is the production of regulatory documents that communicate clinical trial results, study designs, and product safety and efficacy information to health authorities and ethics committees. Documents include study protocols, clinical study reports, investigator's brochures, patient narratives, and the clinical sections of NDA, MAA, and BLA applications. Effective clinical medical writing requires both scientific expertise and detailed knowledge of ICH and agency-specific document requirements.
02
What documents are needed for trials?
A clinical trial requires a study protocol and all protocol amendments, an Investigator's Brochure maintained throughout the study, informed consent documents, and — at completion — a Clinical Study Report. For regulatory submission, NDA and MAA applications additionally require CTD Module 2 clinical summaries, patient narratives for all serious adverse events, and integrated summaries of safety and efficacy where required by the submission type and agency.
Related Services
Complete the Clinical Programme
Pair this with the other clinical functions that run alongside it — one team, one quality system.
Ready to write for submission?
Speak to our team about your programme requirements. We respond within one business day.